Ocular Therapeutix, Inc (OCUL) insider trading
Every open-market stock purchase and sale by Ocular Therapeutix, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Pravin Dugel (Officer) and 5 others sold $568K in the last 90 days.
- Last insider buy: Richard L Lindstrom Md (Director), $461K, 8 months ago.
Last 12 months: insiders bought $461K (1 buy) and sold $3.3M (28 sales). Last close $6.61 on Oct 22, 2026.
Recent OCUL insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 8, 2026 | Todd Anderman (C-suite exec) | Sold | $87.4K |
| Oct 2, 2026 | Jeffrey S. Heier (C-suite exec) | Sold | $76.6K |
| Oct 2, 2026 | Peter Kaiser (C-suite exec) | Sold | $70.4K |
| Aug 31, 2026 | Donald Notman (COO) | Sold | $11.3K |
| Aug 25, 2026 | Pravin Dugel (Officer) | Sold (not open market) | — |
| Aug 25, 2026 | Pravin Dugel (Officer) | Bought (not open market) | — |
| Aug 24, 2026 | Pravin Dugel (Officer) | Sold | $233K |
| Aug 24, 2026 | Jeffrey S. Heier (C-suite exec) | Sold | $35.5K |
| Aug 24, 2026 | Peter Kaiser (C-suite exec) | Sold | $32.7K |
| Aug 24, 2026 | Sanjay Nayak (C-suite exec) | Sold | $20.4K |
| Jun 16, 2026 | Pravin Dugel (Officer) | Bought (not open market) | — |
| Jun 10, 2026 | Charles M Warden (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Charles M Warden (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Merilee Raines (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Richard L Lindstrom Md (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Adrienne L Graves (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Adrienne L Graves (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Seung Suh Hong (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Seung Suh Hong (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Richard L Lindstrom Md (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Leslie J. Williams (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Leslie J. Williams (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Merilee Raines (Director) | Bought (not open market) | — |
| Jun 10, 2026 | Jason Shand Robins (CFO) | Bought (not open market) | — |
| Jun 10, 2026 | Jason Shand Robins (CFO) | Bought (not open market) | — |
Who's trading OCUL
- Todd Anderman, C-suite exec: sold $87.4K (1 sale), last Oct 8, 2026
- Jeffrey S. Heier, C-suite exec: sold $204K (5 sales), last Oct 2, 2026
- Peter Kaiser, C-suite exec: sold $187K (5 sales), last Oct 2, 2026
- Donald Notman, Officer: sold $216K (4 sales), last Aug 31, 2026
- Pravin Dugel, Officer: sold $1.9M (5 sales), last Aug 25, 2026
- Sanjay Nayak, C-suite exec: sold $166K (5 sales), last Aug 24, 2026
- Leslie J. Williams, Director: other filings, last Jun 10, 2026
- Adrienne L Graves, Director: other filings, last Jun 10, 2026
- Seung Suh Hong, Director: other filings, last Jun 10, 2026
- Richard L Lindstrom Md, Director: bought $461K (1 buy), last Jun 10, 2026
- Merilee Raines, Director: other filings, last Jun 10, 2026
- Jason Shand Robins, CFO: other filings, last Jun 10, 2026
- Charles M Warden, Director: other filings, last Jun 10, 2026
- Nadia Waheed, C-suite exec: sold $221K (3 sales), last Jun 3, 2026
- David Wayne Robinson, C-suite exec: other filings, last Jan 21, 2026
Get free alerts when an insider at Ocular Therapeutix, Inc files a new trade →